Clinical Trials
Vertex announces positive results of phase 2 study of...
Vertex Pharmaceuticals Inc announced positive results of a Phase 2 study of the NaV1.8 inhibitor VX-150 in patients with acute pain following bunionectomy surgery. ...
Clinical Trials
OTEZLA® (Apremilast) Phase II Data Showed Clinically significant Improvements...
Celgene Corporation announced that data from a randomized, placebo-controlled, multi-center, phase II clinical trial of apremilast in patients with active ulcerative colitis who had failed...
Clinical Trials
OTEZLA (Apremilast) Phase III Data Showed good results among...
Celgene Corporation announced that data from the phase III RELIEF™ clinical trial of OTEZLA® (apremilast) in patients with active Behçet's Disease with oral ulcers were...
Clinical Trials
Indian Government to come out with a new pharma...
The government is looking to bring in a new pharma policy for implementing the proposed healthcare plan across the country in the next couple of...
Clinical Trials
Flex Databases is Beginning to Implement Blockchain Technology in...
The past few years have created something of a boom in the development of Blockchain technology and its emerging applications within various industries and spheres...
Clinical Trials
ZZ Biotech Announces Preliminary Phase 2 Stroke Trial Results...
ZZ Biotech announced that preliminary results of RHAPSODY, the company’s Phase 2 clinical trial in acute ischemic stroke patients, were presented at the 2018 International...
Clinical Trials
Araclon Biotech Partners with TFS International for Their Alzheimer’s...
After completing a successful phase I partnership with TFS International (TFS), Araclon Biotech a Grifols company, decided to continue the partnership with TFS advancing their...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.